Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read More
Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.
Read More
Dr. Hersh was invited to lecture at the International Congress of Corneal Cross-Linking in Geneva, Switzerland on December 7-8, 2012. He has had the honor of lecturing at this event multiple times. He discussed U.S. Crosslinking Clinical Trials, Corneal Biomechanics in Crosslinking and Predictors of Success for Crosslinking. The Cornea and Laser Eye Institute has […]
Read More